Ignite Creation Date:
2024-05-06 @ 10:26 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03250299
Status:
TERMINATED
Last Update Posted:
2024-06-24
First Post:
2017-07-28
Brief Title:
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Sponsor:
Basilea Pharmaceutica
Organization:
Basilea Pharmaceutica
Organization Data
Organization:
Basilea Pharmaceutica
Class:
INDUSTRY
Study ID:
ABTC 1601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Basilea Pharmaceutica
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | OTHER |